跳至主要内容
临床试验/NCT02418923
NCT02418923已完成不适用

HemoSonics-UVA Spinal Surgery Clinical Study Protocol

University of Virginia1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
assay inter-instrument variability

研究概览

简要总结

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in neurosurgery patients.

详细描述

HemoSonics is developing a novel POC diagnostic device, the Quantra System, to perform whole blood coagulation analysis and which is suitable for use in surgical and intensive care settings. The Quantra System employs a patented technology named sonorheometry, which was invented at the University of Virginia.

Sonorheometry uses ultrasound pulses to characterize the dynamic changes in viscoelastic properties of a blood sample during coagulation and clot lysis. The initial assay performed on the Quantra System will be the surgical assay for monitoring hemostasis during major surgical procedures in adult patients.

A clinical study will be conducted to evaluate the analytical performance as well as compared to existing coagulation monitoring technology

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Subject is scheduled for major deformity correction spine surgery
  • Subject is older than 18 years
  • Subject is willing to participate and he/she has signed a consent form

排除标准

  • • Subject is unable to provide written informed consent
  • Subject is incarcerated at the time of the study
  • Subject is affected by any condition that, in the opinion of the surgical team, may pose additional risks
  • Subjects with renal disease (defined as serum creatinine greater than 1.5 mg/dl)
  • Subjects with history of active liver disease
  • Subjects affected by Factor V Leiden mutation
  • Subjects affected by von Willebrand disease
  • Subjects with an history of thrombotic disease (more than one DVT)

结局指标

主要结局

assay inter-instrument variability

时间窗: 1 day

Demonstrate assay inter-instrument variability below 15%

Establish normal ranges

时间窗: 1 day

Establish normal ranges

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bhiken I. Naik, MD

UVA Anesthesiology Faculty

University of Virginia

研究点 (1)

Loading locations...

相似试验